BA vs MRK: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
The Boeing Company · Industrials
$231.28
+45.0% upside to fair value
Grade C
VS
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
MRK trades at a lower forward P/E
(22.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
MRK |
| Current Price |
$231.28 |
$114.27 |
| Fair Value Estimate |
$335.36 |
$118.00 |
| Upside to Fair Value |
+45.0%
|
+3.3%
|
| Market Cap |
$181.8B |
$282.2B |
| Forward P/E |
83.4x
|
22.4x
|
| EV / EBITDA |
30.8x
|
13.5x
|
| Price / Sales |
2.0x
|
4.3x
|
| Price / FCF |
776.7x
|
20.2x
|
| Revenue Growth YoY |
+14.0%
|
+5.0%
|
| Gross Margin |
4.8%
|
81.9%
|
| Operating Margin |
-5.9%
|
27.5%
|
| Return on Equity |
-8723.1%
|
5.6%
|
| Dividend Yield |
0% |
2.91% |
| FCF Yield |
0.13%
|
4.95%
|
| Analyst Consensus |
Strong Buy
|
Overweight
|
Investment Thesis
The Boeing Company is a leading global aerospace and defense firm operating across commercial airplanes, defense, space and security, and global services segments. Despite a challenging operating margin of negative 5.9% and a high trailing P/E of 83.43, Boeing is currently fairly valued with a fair value estimate of $422.56, implying an 82.7% upside from the current price of $231.28. The company …
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Accumulation Zones
| Metric |
BA |
MRK |
| Zone Low |
$251.52 |
$88.50 |
| Zone High |
$285.06 |
$100.30 |
| In Buy Zone? |
Yes
|
No
|